The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers. [electronic resource]
Producer: 20151001Description: 173-9 p. digitalISSN:- 1598-6357
- Adult
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Cohort Studies
- Colitis, Ulcerative -- drug therapy
- Crohn Disease -- drug therapy
- Female
- Humans
- Infliximab
- Latent Tuberculosis -- chemically induced
- Male
- Mercaptopurine -- adverse effects
- Mycobacterium tuberculosis -- isolation & purification
- Republic of Korea
- Retrospective Studies
- Tuberculosis, Pulmonary -- chemically induced
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.